WOCKHARDT
Back to Cashflow Statement
|
WOCKHARDT Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-54 Cr | ₹409 Cr | ₹334 Cr | ₹-315 Cr | ₹-71 Cr |
What is the latest Cash Flow from Financing Activities ratio of WOCKHARDT ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-54 Cr |
| Mar2025 | ₹409 Cr |
| Mar2024 | ₹334 Cr |
| Mar2023 | ₹-315 Cr |
| Mar2022 | ₹-71 Cr |
How is Cash Flow from Financing Activities of WOCKHARDT Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-54 Cr | Negative | |
| Mar2025 | ₹409 Cr | 22.46 | |
| Mar2024 | ₹334 Cr | Positive | |
| Mar2023 | ₹-315 Cr | Negative | |
| Mar2022 | ₹-71 Cr | - | |
Compare Cash Flow from Financing Activities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹36,829.0 Cr | 3.6% | 20.5% | 52.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | 3.6% |
20.5% |
52.1% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses